The Treatment of Patients with Oligometastatic Lung Cancer

EGFR TKIs: A Marathon or Sprint?

CAR-T Cells for Lung Cancer: Q&A with Dr. Charu Aggarwal

Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

The IASLC Issues Liquid Biopsy Statement to Aid Understanding of Rapid Innovation

Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma

HLA LOH As an Immune Evasive Mechanism in TRACERx NSCLC

NCCN Guidelines Updated for 2018: Keeping Pace with Data

Highlights of the 8th Edition of the TNM Staging System: Practicalities and Tools

The Lung Master Protocol: Results and Updates

Exploring Barriers to Combined-Modality Therapy for LS-SCLC

Oncologic Biologic Biosimilars Are Coming to Market: Are You Ready?